机构:[1]Department of Medicine, Division of Cardiology, Emory University, Atlanta, GA, United States.[2]Department of Cardiology, The First Affiliated Hospital of Kunming Medical University, Kunming, China.内科科室心脏内科昆明医科大学附属第一医院[3]Department of Medicine, Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Emory University, Atlanta, GA, United States[4]Atlanta Veterans Affairs Health Care System, Decatur, GA, United States.[5]Institute of Biomedical Sciences, Faculty of Medicine and Faculty of Life Sciences, Universidad Andres Bello, Santiago, Chile.
This work was supported in part by grants from the National Institute on Alcohol Abuse and Alcoholism (F31AA029938 to KMC (ORCID ID: 0000-0002-9461-4032) and AA026086 to SMY (ORCID ID: 0000-0001- 9309-0233), National Institute of General Medical Sciences (T32GM008602) to Randy A. Hall, and the National Heart, Lung, and Blood Institute, grants HL144741 and HL165252 to ZL, HL150005 to AR (ORCID ID: 0000-0003-1229-5910) and HL095070 to ASM.
第一作者机构:[1]Department of Medicine, Division of Cardiology, Emory University, Atlanta, GA, United States.
通讯作者:
通讯机构:[1]Department of Medicine, Division of Cardiology, Emory University, Atlanta, GA, United States.[5]Institute of Biomedical Sciences, Faculty of Medicine and Faculty of Life Sciences, Universidad Andres Bello, Santiago, Chile.
推荐引用方式(GB/T 7714):
Paredes Felipe,Williams Holly C,Liu Xuesong,et al.The mitochondrial protease ClpP is a druggable target that controls VSMC phenotype by a SIRT1-dependent mechanism[J].REDOX BIOLOGY.2024,73:103203.doi:10.1016/j.redox.2024.103203.
APA:
Paredes Felipe,Williams Holly C,Liu Xuesong,Holden Claire,Bogan Bethany...&San Martin Alejandra.(2024).The mitochondrial protease ClpP is a druggable target that controls VSMC phenotype by a SIRT1-dependent mechanism.REDOX BIOLOGY,73,
MLA:
Paredes Felipe,et al."The mitochondrial protease ClpP is a druggable target that controls VSMC phenotype by a SIRT1-dependent mechanism".REDOX BIOLOGY 73.(2024):103203